TrumpRx.gov is adding 160 prescription drugs to the platform, bringing its total to more than 800 according to a June 5 Truth Social post from President Donald Trump.
The president said the expansion would allow TrumpRx.gov to offer discounted pricing for medications that account for roughly four out of every five prescriptions filled in the U.S. The administration also claims the platform has saved American patients more than $400 million since its February launch.
The announcement came just weeks after billionaire investor Mark Cuban joined President Trump at the White House for the rollout of 600 generic medications on the platform — including atorvastatin, clopidogrel, lisinopril and metformin — with many generics priced under $5. A new tool connecting patients with the lowest-priced pharmacy in their area through partnerships with Cost Plus Drugs, Amazon Pharmacy and GoodRx was also announced at that time.
President Trump did not specify which drugs were added in the latest expansion. The platform currently lists branded drugs under most-favored-nation deals — including Wegovy, Ozempic, Zepbound and Humira — and generic drugs under standard prices. But questions about the program’s actual savings have persisted; some large manufacturers have opted to raise prices abroad rather than cut U.S. prices to meet the policy’s terms.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.